The influence of corticosteroids on the release of novel biomarkers in human endotoxemia

Intensive Care Medicine

Volumn 34, Issue 3, 2008, Pages 518-522

  De Kruif, Martijn D ^a   Lemaire, Lucienne C ^b   Giebelen, Ida A ^a,c   Struck, Joachim ^d   Morgenthaler, Nils G ^d   Papassotiriou, Jana ^d   Elliott, Peter J ^e,f   Van Der Poll, Tom ^a,c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d BRAHMS AG   (Germany)

^e Department of Preclinical Development and Formulations   (United States)

^f GLAXOSMITHKLINE   (United States)

Author keywords

Biological markers; Corticosteroids; Endotoxin; Sepsis

Indexed keywords

ARGININE; BIOLOGICAL MARKER; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; NATRIURETIC FACTOR; PREDNISOLONE; PROADRENOMEDULLIN; VASOPRESSIN;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL RESEARCH; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG INHIBITION; ENDOTOXEMIA; HORMONE RELEASE; HUMAN; MALE; NORMAL HUMAN; PROSPECTIVE STUDY; SEPSIS; UNIVERSITY HOSPITAL;

ADMINISTRATION, ORAL; ADRENOMEDULLIN; ADULT; ARGININE VASOPRESSIN; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CALCITONIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTOXEMIA; HUMANS; INFLAMMATION MEDIATORS; INJECTIONS, INTRAVENOUS; LIPOPOLYSACCHARIDES; MALE; PEPTIDE HORMONES; PREDNISOLONE; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SEPSIS; SEVERITY OF ILLNESS INDEX;

EID: 43049129242     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-007-0955-x     Document Type: Article

References (20)

1. Eichacker PQ, Parent C, Kalil A, Esposito C, Cui X, Banks SM, Gerstenberger EP, Fitz Y, Danner RL, Natanson C (2002) Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. Am J Respir Crit Care Med 166:1197-1205
2. Christ-Crain M, Morgenthaler NG, Struck J, Harbarth S, Bergmann A, Muller B (2005) Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care 9:R816-824
3. Morgenthaler NG, Struck J, Christ-Crain M, Bergmann A, Muller B (2005) Pro-atrial natriuretic peptide is a prognostic marker in sepsis, similar to the APACHE II score: an observational study. Crit Care 9:R37-45
4. Morgenthaler NG, Muller B, Struck J, Bergmann A, Redl H, Christ-Crain M (2007) Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock. Shock 28:219-226
5. Morgenthaler NG, Struck J, Alonso C, Bergmann A (2005) Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem 51:1823-1829
6. Morgenthaler NG, Struck J, Thomas B, Bergmann A (2004) Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma. Clin Chem 50:234-236
7. Morgenthaler NG, Struck J, Alonso C, Bergmann A (2006) Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 52:112-119
8. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY (2006) Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 34:1996-2003
9. Preas HL 2nd, Nylen ES, Snider RH, Becker KL, White JC, Agosti JM, Suffredini AF (2001) Effects of anti-inflammatory agents on serum levels of calcitonin precursors during human experimental endotoxemia. J Infect Dis 184:373-376
10. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Muller B (2004) Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363:600-607
11. Minneci PC, Deans KJ, Banks SM, Eichacker PQ, Natanson C (2004) Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med 141:47-56
12. de Kruif MD, Lemaire LC, Giebelen IA, van Zoelen MA, Pater JM, van den Pangaart PS, Groot AP, de Vos AF, Elliott PJ, Meijers JC, Levi M, van der Poll T (2007) Prednisolone dose-dependently influences inflammation and coagulation during human endotoxemia. J Immunol 178:1845-1851
13. Lowry SF (2005) Human endotoxemia: a model for mechanistic insight and therapeutic targeting. Shock 24(Suppl 1):94-100
14. Morgenthaler NG, Struck J, Fischer-Schulz C, Bergmann A (2002) Sensitive immunoluminometric assay for the detection of procalcitonin. Clin Chem 48:788-790
15. Gegenhuber A, Struck J, Poelz W, Pacher R, Morgenthaler NG, Bergmann A, Haltmayer M, Mueller T (2006) Midregional pro-A-type natriuretic peptide measurements for diagnosis of acute destabilized heart failure in short-of-breath patients: comparison with B-type natriuretic peptide (BNP) and amino-terminal proBNP. Clin Chem 52:827-831
16. Nguyen HB, Smith D (2007) Sepsis in the 21st century: recent definitions and therapeutic advances. Am J Emerg Med 25:564-571
17. Lipiner-Friedman D, Sprung CL, Laterre PF, Weiss Y, Goodman SV, Vogeser M, Briegel J, Keh D, Singer M, Moreno R, Bellissant E, Annane D (2007) Adrenal function in sepsis: the retrospective Corticus cohort study. Crit Care Med 35:1012-1018
18. Laan RF, Jansen TL, van Riel PL (1999) Glucocorticosteroids in the management of rheumatoid arthritis. Rheumatology (Oxford) 38:6-12
19. Lee-Wong M, McClelland S, Chong K, Fernandez E (2006) A case of hydrocortisone desensitization in a patient with radiocontrast-induced anaphylactoid reaction and corticosteroid allergy. Allergy Asthma Proc 27:265-268
20. Cunnington D, Smith N, Steed K, Rosengarten P, Kelly AM, Teichtahl H (2005) Oral versus intravenous corticosteroids in adults hospitalised with acute asthma. Pulm Pharmacol Ther 18:207-212